{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:12Z","timestamp":1792783152871,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Natural Science Foundation Project of Guangxi","award":["2025GXNSFAA069067"],"award-info":[{"award-number":["2025GXNSFAA069067"]}]},{"name":"National Natural Science Foundation of China","award":["82260558"],"award-info":[{"award-number":["82260558"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12934-0","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:57:18Z","timestamp":1792166238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ALKBH5-regulated circ_0032649, acting as a sponge for miR-4755-3p to upregulate ORAI2, facilitates intrahepatic cholangiocarcinoma tumorigenicity"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7658-870X","authenticated-orcid":false,"given":"Yi","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1418-187X","authenticated-orcid":false,"given":"Qiuhuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8088-2793","authenticated-orcid":false,"given":"Xuanchao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1753-2553","authenticated-orcid":false,"given":"Rongjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5237-128X","authenticated-orcid":false,"given":"Shaowei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8332-9840","authenticated-orcid":false,"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8101-0742","authenticated-orcid":false,"given":"Tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7291-8136","authenticated-orcid":false,"given":"Xiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4779-264X","authenticated-orcid":false,"given":"Dongyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9239-8893","authenticated-orcid":false,"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6348-8427","authenticated-orcid":false,"given":"Zhenyong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4267-935X","authenticated-orcid":false,"given":"Yuntian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"6","key":"12934_CR1","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1007\/s00261-024-04732-8","volume":"50","author":"M El Homsi","year":"2025","unstructured":"El Homsi M, Alkhasawneh A, Arif-Tiwari H, Czeyda-Pommersheim F, Khasawneh H, Kierans AS et al (2025) Classification of intrahepatic cholangiocarcinoma. Abdom Radiol (NY) 50(6):2522\u20132532. https:\/\/doi.org\/10.1007\/s00261-024-04732-8","journal-title":"Abdom Radiol (NY)"},{"issue":"2","key":"12934_CR2","doi-asserted-by":"publisher","first-page":"107064","DOI":"10.1016\/j.ejso.2023.107064","volume":"51","author":"M Qurashi","year":"2025","unstructured":"Qurashi M, Vithayathil M, Khan SA (2025) Epidemiology of cholangiocarcinoma. Eur J Surg Oncol 51(2):107064. https:\/\/doi.org\/10.1016\/j.ejso.2023.107064","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"12934_CR3","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1007\/s00261-025-04856-5","volume":"50","author":"BG Childers","year":"2025","unstructured":"Childers BG, Denbo JW, Kim RD, Hoffe SE, Glushko T, Qayyum A et al (2025) Intrahepatic cholangiocarcinoma: role of imaging as a critical component for multi-disciplinary treatment approach. Abdom Radiol (NY) 50(9):4110\u20134124. https:\/\/doi.org\/10.1007\/s00261-025-04856-5","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"12934_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","volume":"79","author":"EAS Liver","year":"2023","unstructured":"Liver EAS (2023) EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma. J Hepatol 79(1):181\u2013208. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.010","journal-title":"J Hepatol"},{"key":"12934_CR5","doi-asserted-by":"publisher","unstructured":"Gujarathi R, Peshin S, Zhang X, Bachini M, Meeks MN, Shroff RT et al (2025) Intrahepatic cholangiocarcinoma: Insights on molecular testing, targeted therapies, and future directions from a multidisciplinary panel. Hepatol Commun 9(7). https:\/\/doi.org\/10.1097\/hc9.0000000000000743","DOI":"10.1097\/hc9.0000000000000743"},{"issue":"15","key":"12934_CR6","doi-asserted-by":"publisher","first-page":"104901","DOI":"10.3748\/wjg.v31.i15.104901","volume":"31","author":"JJ Liu","year":"2025","unstructured":"Liu JJ, Zhou M, Yuan T, Huang ZY, Zhang ZY (2025) Conversion treatment for advanced intrahepatic cholangiocarcinoma: Opportunities and challenges. World J Gastroenterol 31(15):104901. https:\/\/doi.org\/10.3748\/wjg.v31.i15.104901","journal-title":"World J Gastroenterol"},{"issue":"1","key":"12934_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12029-026-01397-y","volume":"57","author":"M Barsch","year":"2026","unstructured":"Barsch M, Dopfer EP, Schultheis AM, Quante M (2026) Molecular Testing for Intrahepatic Cholangiocarcinoma: What, When, How? J Gastrointest Cancer 57(1):15. https:\/\/doi.org\/10.1007\/s12029-026-01397-y","journal-title":"J Gastrointest Cancer"},{"key":"12934_CR8","doi-asserted-by":"publisher","first-page":"112056","DOI":"10.1016\/j.ejrad.2025.112056","volume":"187","author":"T Glushko","year":"2025","unstructured":"Glushko T, Costello J, Chima R, McGettigan M, Kim R, Jeong D et al (2025) Molecular signatures of intrahepatic cholangiocarcinoma: role in targeted therapy selection. Eur J Radiol 187:112056. https:\/\/doi.org\/10.1016\/j.ejrad.2025.112056","journal-title":"Eur J Radiol"},{"issue":"10","key":"12934_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s12032-025-03018-3","volume":"42","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Xing X, Liu J, Hou L, Xu Y, Zhai B et al (2025) The diverse roles of circular RNAs in cholangiocarcinoma. Med Oncol 42(10):455. https:\/\/doi.org\/10.1007\/s12032-025-03018-3","journal-title":"Med Oncol"},{"key":"12934_CR10","doi-asserted-by":"publisher","first-page":"154755","DOI":"10.1016\/j.prp.2023.154755","volume":"249","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Chen C, Han B, Wang Y, Liu Y, Liu Q et al (2023) Circular RNA in cholangiocarcinoma: A systematic review and bibliometric analysis. Pathol Res Pract 249:154755. https:\/\/doi.org\/10.1016\/j.prp.2023.154755","journal-title":"Pathol Res Pract"},{"issue":"1","key":"12934_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12672-025-03571-3","volume":"17","author":"Z Yan","year":"2025","unstructured":"Yan Z, Du L, Zhang X, Liu Y, Zhang Y, Deng J et al (2025) The functions of circular RNAs and long noncoding RNAs in cholangiocarcinoma. Discov Oncol 17(1):44. https:\/\/doi.org\/10.1007\/s12672-025-03571-3","journal-title":"Discov Oncol"},{"key":"12934_CR12","doi-asserted-by":"publisher","first-page":"215980","DOI":"10.1016\/j.canlet.2022.215980","volume":"553","author":"W Liao","year":"2023","unstructured":"Liao W, Feng Q, Liu H, Du J, Chen X, Zeng Y (2023) Circular RNAs in cholangiocarcinoma. Cancer Lett 553:215980. https:\/\/doi.org\/10.1016\/j.canlet.2022.215980","journal-title":"Cancer Lett"},{"issue":"1","key":"12934_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13046-024-03006-x","volume":"43","author":"J Li","year":"2024","unstructured":"Li J, Xu X, Xu K, Zhou X, Wu K, Yao Y et al (2024) N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1. J Exp Clin Cancer Res 43(1):119. https:\/\/doi.org\/10.1186\/s13046-024-03006-x","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"12934_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jhep.2021.08.027","volume":"76","author":"Q Chen","year":"2022","unstructured":"Chen Q, Wang H, Li Z, Li F, Liang L, Zou Y et al (2022) Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription. J Hepatol 76(1):135\u2013147. https:\/\/doi.org\/10.1016\/j.jhep.2021.08.027","journal-title":"J Hepatol"},{"issue":"38","key":"12934_CR15","doi-asserted-by":"publisher","first-page":"e2402329","DOI":"10.1002\/advs.202402329","volume":"11","author":"RX Chen","year":"2024","unstructured":"Chen RX, Liu SC, Kan XC, Wang YR, Wang JF, Wang TL et al (2024) CircUGP2 Suppresses Intrahepatic Cholangiocarcinoma Progression via p53 Signaling Through Interacting With PURB to Regulate ADGRB1 Transcription and Sponging miR-3191-5p. Adv Sci (Weinh) 11(38):e2402329. https:\/\/doi.org\/10.1002\/advs.202402329","journal-title":"Adv Sci (Weinh)"},{"key":"12934_CR16","doi-asserted-by":"publisher","first-page":"112447","DOI":"10.1016\/j.cellsig.2026.112447","volume":"143","author":"T Chen","year":"2026","unstructured":"Chen T, Wang Y, Xie C, Li Y, Li Q, Wang B et al (2026) Circ_0057105 promotes intrahepatic cholangiocarcinoma progression by sponging miR-1290 and regulating the MDM2\/P53 pathway. Cell Signal 143:112447. https:\/\/doi.org\/10.1016\/j.cellsig.2026.112447","journal-title":"Cell Signal"},{"key":"12934_CR17","doi-asserted-by":"publisher","first-page":"101858","DOI":"10.1016\/j.tranon.2023.101858","volume":"41","author":"Y Gao","year":"2024","unstructured":"Gao Y, Yu M, Liu Z, Liu Y, Kong Z, Zhu C et al (2024) m(6)A demethylase ALKBH5 maintains stemness of intrahepatic cholangiocarcinoma by sustaining BUB1B expression and cell proliferation. Transl Oncol 41:101858. https:\/\/doi.org\/10.1016\/j.tranon.2023.101858","journal-title":"Transl Oncol"},{"issue":"18","key":"12934_CR18","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1158\/0008-5472.Can-21-0468","volume":"81","author":"X Qiu","year":"2021","unstructured":"Qiu X, Yang S, Wang S, Wu J, Zheng B, Wang K et al (2021) M(6)A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma. Cancer Res 81(18):4778\u20134793. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-0468","journal-title":"Cancer Res"},{"issue":"1","key":"12934_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13059-014-0571-3","volume":"16","author":"Y Gao","year":"2015","unstructured":"Gao Y, Wang J, Zhao F (2015) CIRI: an efficient and unbiased algorithm for de novo circular RNA identification. Genome Biol 16(1):4. https:\/\/doi.org\/10.1186\/s13059-014-0571-3","journal-title":"Genome Biol"},{"key":"12934_CR20","doi-asserted-by":"publisher","first-page":"11215","DOI":"10.1038\/ncomms11215","volume":"7","author":"Q Zheng","year":"2016","unstructured":"Zheng Q, Bao C, Guo W, Li S, Chen J, Chen B et al (2016) Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun 7:11215. https:\/\/doi.org\/10.1038\/ncomms11215","journal-title":"Nat Commun"},{"issue":"Pt 2","key":"12934_CR21","doi-asserted-by":"publisher","first-page":"147999","DOI":"10.1016\/j.ijbiomac.2025.147999","volume":"330","author":"B Huang","year":"2025","unstructured":"Huang B, Zhang X, Chen J, Wang H (2025) ALKBH5: a double-edged sword in cancer ferroptosis regulation: A review. Int J Biol Macromol 330(Pt 2):147999. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.147999","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"12934_CR22","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1186\/s12967-025-06938-w","volume":"23","author":"R An","year":"2025","unstructured":"An R, Shao Y, Gu W (2025) Mechanistic insights into the role of RNA demethylase ALKBH5 in malignant tumor therapy. J Transl Med 23(1):905. https:\/\/doi.org\/10.1186\/s12967-025-06938-w","journal-title":"J Transl Med"},{"key":"12934_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2026.01.009","author":"W Sun","year":"2026","unstructured":"Sun W, Dai W, Chen C, Qiu Q, Chen J, Chen J et al (2026) METTL4 enhances GLI1 translation through m(6)Am modification to promote tumor progression as a therapeutic target for hepatocellular carcinoma. J Adv Res. https:\/\/doi.org\/10.1016\/j.jare.2026.01.009","journal-title":"J Adv Res"},{"issue":"17","key":"12934_CR24","doi-asserted-by":"publisher","first-page":"e16996","DOI":"10.1002\/advs.202416996","volume":"13","author":"W Sun","year":"2026","unstructured":"Sun W, Yuan Y, Qiu Q, Tan K, Li X, Li H et al (2026) TRIM47 Regulates Energy Metabolism via Glycolytic Reprogramming to Drive Hepatocellular Carcinoma Progression and Represents an Efficient Therapeutic Target. Adv Sci (Weinh) 13(17):e16996. https:\/\/doi.org\/10.1002\/advs.202416996","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"12934_CR25","doi-asserted-by":"publisher","first-page":"965","DOI":"10.7150\/thno.102964","volume":"15","author":"Y Yuan","year":"2025","unstructured":"Yuan Y, Sun W, Xie J, Zhang Z, Luo J, Han X et al (2025) RNA nanotherapeutics for hepatocellular carcinoma treatment. Theranostics 15(3):965\u2013992. https:\/\/doi.org\/10.7150\/thno.102964","journal-title":"Theranostics"},{"issue":"1","key":"12934_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13046-022-02462-7","volume":"41","author":"L Liang","year":"2022","unstructured":"Liang L, Zhu Y, Li J, Zeng J, Wu L (2022) ALKBH5-mediated m6A modification of circCCDC134 facilitates cervical cancer metastasis by enhancing HIF1A transcription. J Exp Clin Cancer Res 41(1):261. https:\/\/doi.org\/10.1186\/s13046-022-02462-7","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"12934_CR27","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1111\/cas.15772","volume":"114","author":"X Ji","year":"2023","unstructured":"Ji X, Lv C, Huang J, Dong W, Sun W, Zhang H (2023) ALKBH5-induced circular RNA NRIP1 promotes glycolysis in thyroid cancer cells by targeting PKM2. Cancer Sci 114(6):2318\u20132334. https:\/\/doi.org\/10.1111\/cas.15772","journal-title":"Cancer Sci"},{"key":"12934_CR28","doi-asserted-by":"publisher","first-page":"124118","DOI":"10.1016\/j.lfs.2025.124118","volume":"385","author":"C Cai","year":"2026","unstructured":"Cai C, Peng X, Han Y, Zhu Y (2026) circCNN2 drives endometrial cancer progression through ALKBH5\/YTHDF2-mediated m6A regulation and miR-615-5p sponging. Life Sci 385:124118. https:\/\/doi.org\/10.1016\/j.lfs.2025.124118","journal-title":"Life Sci"},{"issue":"7","key":"12934_CR29","doi-asserted-by":"publisher","first-page":"e1318","DOI":"10.1002\/ctm2.1318","volume":"13","author":"Y Shao","year":"2023","unstructured":"Shao Y, Liu Z, Song X, Sun R, Zhou Y, Zhang D et al (2023) ALKBH5\/YTHDF2-mediated m6A modification of circAFF2 enhances radiosensitivity of colorectal cancer by inhibiting Cullin neddylation. Clin Transl Med 13(7):e1318. https:\/\/doi.org\/10.1002\/ctm2.1318","journal-title":"Clin Transl Med"},{"key":"12934_CR30","doi-asserted-by":"publisher","first-page":"122367","DOI":"10.1016\/j.envpol.2023.122367","volume":"336","author":"S Yao","year":"2023","unstructured":"Yao S, Chen X, Hu N, Zhang N, Qiu M, Jia Y et al (2023) Benzo[a]pyrene-induced up-regulation of circ_0003552 via ALKBH5-mediated m(6)A modification promotes DNA damage in human bronchial epithelial cells. Environ Pollut 336:122367. https:\/\/doi.org\/10.1016\/j.envpol.2023.122367","journal-title":"Environ Pollut"},{"issue":"1","key":"12934_CR31","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1186\/s12967-024-05716-4","volume":"22","author":"X Zhu","year":"2024","unstructured":"Zhu X, Zhang P (2024) m6A-modified circXPO1 accelerates colorectal cancer progression via interaction with FMRP to promote WWC2 mRNA decay. J Transl Med 22(1):931. https:\/\/doi.org\/10.1186\/s12967-024-05716-4","journal-title":"J Transl Med"},{"issue":"9","key":"12934_CR32","doi-asserted-by":"publisher","first-page":"e0222024","DOI":"10.1371\/journal.pone.0222024","volume":"14","author":"N Satomi-Tsushita","year":"2019","unstructured":"Satomi-Tsushita N, Shimomura A, Matsuzaki J, Yamamoto Y, Kawauchi J, Takizawa S et al (2019) Serum microRNA-based prediction of responsiveness to eribulin in metastatic breast cancer. PLoS ONE 14(9):e0222024. https:\/\/doi.org\/10.1371\/journal.pone.0222024","journal-title":"PLoS ONE"},{"issue":"5","key":"12934_CR33","doi-asserted-by":"publisher","first-page":"110479","DOI":"10.1016\/j.ygeno.2022.110479","volume":"114","author":"J Yan","year":"2022","unstructured":"Yan J, Yu W, Lu C, Wang G, Liu C, Jiang L et al (2022) Orai2 deficiency attenutates experimental colitis by facilitating the colonization of Akkermansia muciniphila. Genomics 114(5):110479. https:\/\/doi.org\/10.1016\/j.ygeno.2022.110479","journal-title":"Genomics"},{"issue":"4","key":"12934_CR34","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1158\/0008-5472.Can-20-0049","volume":"81","author":"S Wu","year":"2021","unstructured":"Wu S, Chen M, Huang J, Zhang F, Lv Z, Jia Y et al (2021) ORAI2 Promotes Gastric Cancer Tumorigenicity and Metastasis through PI3K\/Akt Signaling and MAPK-Dependent Focal Adhesion Disassembly. Cancer Res 81(4):986\u20131000. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-0049","journal-title":"Cancer Res"},{"issue":"24","key":"12934_CR35","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1038\/s41388-023-02707-5","volume":"42","author":"K Liu","year":"2023","unstructured":"Liu K, Xu P, Lv J, Ge H, Yan Z, Huang S et al (2023) Peritoneal high-fat environment promotes peritoneal metastasis of gastric cancer cells through activation of NSUN2-mediated ORAI2 m5C modification. Oncogene 42(24):1980\u20131993. https:\/\/doi.org\/10.1038\/s41388-023-02707-5","journal-title":"Oncogene"},{"issue":"6","key":"12934_CR36","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.bbamcr.2016.11.014","volume":"1864","author":"R Diez-Bello","year":"2017","unstructured":"Diez-Bello R, Jardin I, Salido GM, Rosado JA (2017) Orai1 and Orai2 mediate store-operated calcium entry that regulates HL60 cell migration and FAK phosphorylation. Biochim Biophys Acta Mol Cell Res 1864(6):1064\u20131070. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.11.014","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"12934_CR37","doi-asserted-by":"publisher","first-page":"118372","DOI":"10.1016\/j.lfs.2020.118372","volume":"261","author":"AK Singh","year":"2020","unstructured":"Singh AK, Roy NK, Bordoloi D, Padmavathi G, Banik K, Khwairakpam AD et al (2020) Orai-1 and Orai-2 regulate oral cancer cell migration and colonisation by suppressing Akt\/mTOR\/NF-\u03baB signalling. Life Sci 261:118372. https:\/\/doi.org\/10.1016\/j.lfs.2020.118372","journal-title":"Life Sci"},{"key":"12934_CR38","doi-asserted-by":"publisher","unstructured":"Sanchez-Collado J, Lopez JJ, Cantonero C, Jardin I, Regod\u00f3n S, Redondo PC et al (2021) Orai2 Modulates Store-Operated Ca(2+) Entry and Cell Cycle Progression in Breast Cancer Cells. Cancers (Basel) 14(1). https:\/\/doi.org\/10.3390\/cancers14010114","DOI":"10.3390\/cancers14010114"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12934-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12934-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12934-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:57:21Z","timestamp":1792166241000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12934-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12934"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12934-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"24 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All research involving human participants complied with Helsinki Declaration. The collection and use of human clinical tissues were approved by the Ethics Committee of The People\u2019s Hospital of Guangxi Zhuang Autonomous Region (Ethics No. Lunli-KY-GZR-2022-054), and all participants provided written informed consent before inclusion in the study. All animal experiments were performed in accordance with the ARRIVE guidelines and were approved by the Institutional Animal Care and Use Committee (IACUC) of Jiangxi Zhonghong Boyuan Biotechnology Co., Ltd. (Approval No. 2025-06-Zvast-027).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1749"}}